{"transactions":[{"id":1404572,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":87471,"kind":"person","name":"Fisher Stewart","position":1,"cik":"0001824863","reported_name":"Fisher Stewart","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Performance Restricted Stock Units","published_at":"2024-09-17T21:12:16.000Z","date":"2024-09-16","kind":"exercise","planned":false,"acquired":false,"shares":2250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each performance restricted stock unit (\"PRSU\") represents the contingent right to receive one share of the Issuer's Common Stock upon vesting and settlement. 4,500 PRSUs shall vest upon satisfaction of three escalating share price vesting milestones, and the remaining PRSUs vest upon satisfaction of certain discovery and clinical milestones."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each performance restricted stock unit (\"PRSU\") represents the contingent right to receive one share of the Issuer's Common Stock upon vesting and settlement. 4,500 PRSUs shall vest upon satisfaction of three escalating share price vesting milestones, and the remaining PRSUs vest upon satisfaction of certain discovery and clinical milestones."}],"balance_after":14250,"derivative":{"expiration_date":"2025-02-28","underlying":"Common Stock","underlying_shares":2250},"source":{"system":"sec-edgar","filing":"0001662579-24-000081","document":"wk-form4_1726607530.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1662579/000166257924000081/wk-form4_1726607530.xml","form_type":"4"}},{"id":1404571,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":87471,"kind":"person","name":"Fisher Stewart","position":1,"cik":"0001824863","reported_name":"Fisher Stewart","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2024-09-17T21:12:16.000Z","date":"2024-09-16","kind":"tax_withholding","planned":false,"acquired":false,"shares":661,"price":6.36,"value":4203.96,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting and settlement of PRSUs and does not represent a sale by the Reporting Person."}],"balance_after":130710,"source":{"system":"sec-edgar","filing":"0001662579-24-000081","document":"wk-form4_1726607530.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1662579/000166257924000081/wk-form4_1726607530.xml","form_type":"4"}},{"id":1404570,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":87471,"kind":"person","name":"Fisher Stewart","position":1,"cik":"0001824863","reported_name":"Fisher Stewart","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2024-09-17T21:12:16.000Z","date":"2024-09-16","kind":"exercise","planned":false,"acquired":true,"shares":2250,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each performance restricted stock unit (\"PRSU\") represents the contingent right to receive one share of the Issuer's Common Stock upon vesting and settlement. 4,500 PRSUs shall vest upon satisfaction of three escalating share price vesting milestones, and the remaining PRSUs vest upon satisfaction of certain discovery and clinical milestones."}],"balance_after":131371,"source":{"system":"sec-edgar","filing":"0001662579-24-000081","document":"wk-form4_1726607530.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1662579/000166257924000081/wk-form4_1726607530.xml","form_type":"4"}},{"id":1585921,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":87471,"kind":"person","name":"Fisher Stewart","position":1,"cik":"0001824863","reported_name":"Fisher Stewart","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-03-09T00:26:11.000Z","date":"2024-03-07","kind":"grant","planned":false,"acquired":true,"shares":118000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On March 7, 2024, the Compensation Committee of the Issuer's Board of Directors approved an option repricing. All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On March 7, 2024, the Compensation Committee of the Issuer's Board of Directors approved an option repricing. All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares underlying this option shall vest and become exercisable in sixteen equal quarterly installments following the grant date, with the first installment vesting on May 14, 2022."}],"balance_after":118000,"derivative":{"exercise_price":19,"expiration_date":"2032-02-13","underlying":"Common Stock","underlying_shares":118000},"source":{"system":"sec-edgar","filing":"0001662579-24-000030","document":"wk-form4_1709943962.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1662579/000166257924000030/wk-form4_1709943962.xml","form_type":"4"}},{"id":1585920,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":87471,"kind":"person","name":"Fisher Stewart","position":1,"cik":"0001824863","reported_name":"Fisher Stewart","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-03-09T00:26:11.000Z","date":"2024-03-07","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":118000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On March 7, 2024, the Compensation Committee of the Issuer's Board of Directors approved an option repricing. All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On March 7, 2024, the Compensation Committee of the Issuer's Board of Directors approved an option repricing. All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares underlying this option shall vest and become exercisable in sixteen equal quarterly installments following the grant date, with the first installment vesting on May 14, 2022."}],"balance_after":0,"derivative":{"exercise_price":22.71,"expiration_date":"2032-02-13","underlying":"Common Stock","underlying_shares":118000},"source":{"system":"sec-edgar","filing":"0001662579-24-000030","document":"wk-form4_1709943962.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1662579/000166257924000030/wk-form4_1709943962.xml","form_type":"4"}},{"id":1585919,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":87471,"kind":"person","name":"Fisher Stewart","position":1,"cik":"0001824863","reported_name":"Fisher Stewart","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-03-09T00:26:11.000Z","date":"2024-03-07","kind":"grant","planned":false,"acquired":true,"shares":94950,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On March 7, 2024, the Compensation Committee of the Issuer's Board of Directors approved an option repricing. All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On March 7, 2024, the Compensation Committee of the Issuer's Board of Directors approved an option repricing. All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option shall vest and become exercisable in 16 equal quarterly installments, with the first installment vesting on May 11, 2021."}],"balance_after":94950,"derivative":{"exercise_price":19,"expiration_date":"2031-02-10","underlying":"Common Stock","underlying_shares":94950},"source":{"system":"sec-edgar","filing":"0001662579-24-000030","document":"wk-form4_1709943962.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1662579/000166257924000030/wk-form4_1709943962.xml","form_type":"4"}},{"id":1585918,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":87471,"kind":"person","name":"Fisher Stewart","position":1,"cik":"0001824863","reported_name":"Fisher Stewart","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-03-09T00:26:11.000Z","date":"2024-03-07","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":94950,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On March 7, 2024, the Compensation Committee of the Issuer's Board of Directors approved an option repricing. All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On March 7, 2024, the Compensation Committee of the Issuer's Board of Directors approved an option repricing. All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option shall vest and become exercisable in 16 equal quarterly installments, with the first installment vesting on May 11, 2021."}],"balance_after":0,"derivative":{"exercise_price":45.54,"expiration_date":"2031-02-10","underlying":"Common Stock","underlying_shares":94950},"source":{"system":"sec-edgar","filing":"0001662579-24-000030","document":"wk-form4_1709943962.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1662579/000166257924000030/wk-form4_1709943962.xml","form_type":"4"}},{"id":1640523,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":87471,"kind":"person","name":"Fisher Stewart","position":1,"cik":"0001824863","reported_name":"Fisher Stewart","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-02-15T22:04:22.000Z","date":"2024-02-14","kind":"grant","planned":false,"acquired":true,"shares":122800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares underlying this option shall vest and become exercisable in sixteen equal quarterly installments following the grant date, with the first installment vesting on May 14, 2024."}],"balance_after":122800,"derivative":{"exercise_price":7.31,"expiration_date":"2034-02-13","underlying":"Common Stock","underlying_shares":122800},"source":{"system":"sec-edgar","filing":"0001662579-24-000016","document":"wk-form4_1708034642.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1662579/000166257924000016/wk-form4_1708034642.xml","form_type":"4"}},{"id":1640522,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":87471,"kind":"person","name":"Fisher Stewart","position":1,"cik":"0001824863","reported_name":"Fisher Stewart","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2024-02-15T22:04:22.000Z","date":"2024-02-14","kind":"grant","planned":false,"acquired":true,"shares":27300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents RSUs. Each RSU represents the contingent right to receive one share of the Issuer's Common Stock upon vesting and settlement. The RSUs shall vest in four equal annual installments following the grant date, with the first installment vesting on February 14, 2025."}],"balance_after":129121,"source":{"system":"sec-edgar","filing":"0001662579-24-000016","document":"wk-form4_1708034642.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1662579/000166257924000016/wk-form4_1708034642.xml","form_type":"4"}},{"id":1640521,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":87471,"kind":"person","name":"Fisher Stewart","position":1,"cik":"0001824863","reported_name":"Fisher Stewart","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2024-02-15T22:04:22.000Z","date":"2024-02-13","kind":"tax_withholding","planned":false,"acquired":false,"shares":2255,"price":6.53,"value":14725.15,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units (\"RSUs\") and does not represent a sale by the Reporting Person."}],"balance_after":101821,"source":{"system":"sec-edgar","filing":"0001662579-24-000016","document":"wk-form4_1708034642.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1662579/000166257924000016/wk-form4_1708034642.xml","form_type":"4"}},{"id":1776831,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":87471,"kind":"person","name":"Fisher Stewart","position":1,"cik":"0001824863","reported_name":"Fisher Stewart","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-09-19T23:23:29.000Z","date":"2023-09-18","kind":"grant","planned":false,"acquired":true,"shares":120000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest in full on September 18, 2025, subject to the Reporting Person's continued service on such date."}],"balance_after":120000,"derivative":{"exercise_price":2.15,"expiration_date":"2033-09-17","underlying":"Common Stock","underlying_shares":120000},"source":{"system":"sec-edgar","filing":"0001662579-23-000100","document":"wk-form4_1695165800.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1662579/000166257923000100/wk-form4_1695165800.xml","form_type":"4"}},{"id":1791695,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":87471,"kind":"person","name":"Fisher Stewart","position":1,"cik":"0001824863","reported_name":"Fisher Stewart","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Performance Restricted Stock Units","published_at":"2023-08-31T20:10:27.000Z","date":"2023-08-30","kind":"exercise","planned":false,"acquired":false,"shares":2250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each performance restricted stock unit (\"PRSU\") represents the contingent right to receive one share of the Issuer's Common Stock upon vesting and settlement. 4,500 PRSUs shall vest upon satisfaction of three escalating share price vesting milestones, and the remaining PRSUs vest upon satisfaction of certain discovery and clinical milestones."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each performance restricted stock unit (\"PRSU\") represents the contingent right to receive one share of the Issuer's Common Stock upon vesting and settlement. 4,500 PRSUs shall vest upon satisfaction of three escalating share price vesting milestones, and the remaining PRSUs vest upon satisfaction of certain discovery and clinical milestones."}],"balance_after":16500,"derivative":{"expiration_date":"2025-02-28","underlying":"Common Stock","underlying_shares":2250},"source":{"system":"sec-edgar","filing":"0001662579-23-000082","document":"wk-form4_1693512618.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1662579/000166257923000082/wk-form4_1693512618.xml","form_type":"4"}},{"id":1791694,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":87471,"kind":"person","name":"Fisher Stewart","position":1,"cik":"0001824863","reported_name":"Fisher Stewart","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2023-08-31T20:10:27.000Z","date":"2023-08-30","kind":"tax_withholding","planned":false,"acquired":false,"shares":661,"price":2.93,"value":1936.73,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting and settlement of PRSUs and does not represent a sale by the Reporting Person."}],"balance_after":104076,"source":{"system":"sec-edgar","filing":"0001662579-23-000082","document":"wk-form4_1693512618.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1662579/000166257923000082/wk-form4_1693512618.xml","form_type":"4"}},{"id":1791693,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":87471,"kind":"person","name":"Fisher Stewart","position":1,"cik":"0001824863","reported_name":"Fisher Stewart","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2023-08-31T20:10:27.000Z","date":"2023-08-30","kind":"exercise","planned":false,"acquired":true,"shares":2250,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each performance restricted stock unit (\"PRSU\") represents the contingent right to receive one share of the Issuer's Common Stock upon vesting and settlement. 4,500 PRSUs shall vest upon satisfaction of three escalating share price vesting milestones, and the remaining PRSUs vest upon satisfaction of certain discovery and clinical milestones."}],"balance_after":104737,"source":{"system":"sec-edgar","filing":"0001662579-23-000082","document":"wk-form4_1693512618.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1662579/000166257923000082/wk-form4_1693512618.xml","form_type":"4"}},{"id":2013150,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":87471,"kind":"person","name":"Fisher Stewart","position":1,"cik":"0001824863","reported_name":"Fisher Stewart","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-02-15T21:46:11.000Z","date":"2023-02-13","kind":"grant","acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares underlying this option shall vest and become exercisable in sixteen equal quarterly installments following the grant date, with the first installment vesting on May 13, 2023."}],"balance_after":125000,"derivative":{"exercise_price":5.67,"expiration_date":"2033-02-12","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001662579-23-000039","document":"wf-form4_167649755275761.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1662579/000166257923000039/wf-form4_167649755275761.xml","form_type":"4"}},{"id":2013149,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":87471,"kind":"person","name":"Fisher Stewart","position":1,"cik":"0001824863","reported_name":"Fisher Stewart","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2023-02-15T21:46:11.000Z","date":"2023-02-13","kind":"grant","acquired":true,"shares":26000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (\"RSUs\"). Each RSU represents the contingent right to receive one share of the Issuer's Common Stock upon vesting and settlement. The RSUs shall vest in four equal annual installments following the grant date, with the first installment vesting on February 13, 2024."}],"balance_after":102487,"source":{"system":"sec-edgar","filing":"0001662579-23-000039","document":"wf-form4_167649755275761.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1662579/000166257923000039/wf-form4_167649755275761.xml","form_type":"4"}},{"id":2038208,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":87471,"kind":"person","name":"Fisher Stewart","position":1,"cik":"0001824863","reported_name":"Fisher Stewart","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Performance Restricted Stock Units","published_at":"2023-02-01T21:08:47.000Z","date":"2023-01-30","kind":"exercise","acquired":false,"shares":3750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each performance restricted stock unit (\"PRSU\") represents the contingent right to receive one share of the Issuer's Common Stock upon vesting and settlement. 4,500 PRSUs shall vest upon satisfaction of three escalating share price vesting milestones, and the remaining PRSUs vest upon satisfaction of certain discovery and clinical milestones."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each performance restricted stock unit (\"PRSU\") represents the contingent right to receive one share of the Issuer's Common Stock upon vesting and settlement. 4,500 PRSUs shall vest upon satisfaction of three escalating share price vesting milestones, and the remaining PRSUs vest upon satisfaction of certain discovery and clinical milestones."}],"balance_after":18750,"derivative":{"expiration_date":"2025-02-28","underlying":"Common Stock","underlying_shares":3750},"source":{"system":"sec-edgar","filing":"0001662579-23-000018","document":"wf-form4_167528571311726.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1662579/000166257923000018/wf-form4_167528571311726.xml","form_type":"4"}},{"id":2038207,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":87471,"kind":"person","name":"Fisher Stewart","position":1,"cik":"0001824863","reported_name":"Fisher Stewart","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2023-02-01T21:08:47.000Z","date":"2023-01-30","kind":"tax_withholding","acquired":false,"shares":1301,"price":7.78,"value":10121.78,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting and settlement of PRSUs and does not represent a sale by the Reporting Person."}],"balance_after":76487,"source":{"system":"sec-edgar","filing":"0001662579-23-000018","document":"wf-form4_167528571311726.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1662579/000166257923000018/wf-form4_167528571311726.xml","form_type":"4"}},{"id":2038206,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":87471,"kind":"person","name":"Fisher Stewart","position":1,"cik":"0001824863","reported_name":"Fisher Stewart","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2023-02-01T21:08:47.000Z","date":"2023-01-30","kind":"exercise","acquired":true,"shares":3750,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each performance restricted stock unit (\"PRSU\") represents the contingent right to receive one share of the Issuer's Common Stock upon vesting and settlement. 4,500 PRSUs shall vest upon satisfaction of three escalating share price vesting milestones, and the remaining PRSUs vest upon satisfaction of certain discovery and clinical milestones."}],"balance_after":77788,"source":{"system":"sec-edgar","filing":"0001662579-23-000018","document":"wf-form4_167528571311726.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1662579/000166257923000018/wf-form4_167528571311726.xml","form_type":"4"}},{"id":2232208,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":87471,"kind":"person","name":"Fisher Stewart","position":1,"cik":"0001824863","reported_name":"Fisher Stewart","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2022-06-14T20:45:46.000Z","date":"2022-05-26","kind":"tax_withholding","acquired":false,"shares":1102,"price":7.01,"value":7725.02,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting and settlement of performance restricted stock units and does not represent a sale by the Reporting Person."}],"balance_after":74038,"source":{"system":"sec-edgar","filing":"0001209191-22-036715","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1662579/000120919122036715/doc4a.xml","form_type":"4/A","original_submission_date":"2022-05-27"}},{"id":2252691,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":87471,"kind":"person","name":"Fisher Stewart","position":1,"cik":"0001824863","reported_name":"Fisher Stewart","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Performance Restricted Stock Units","published_at":"2022-05-27T20:15:50.000Z","date":"2022-05-25","kind":"exercise","acquired":false,"shares":3750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each performance restricted stock unit (\"PRSU\") represents the contingent right to receive one share of the Issuer's Common Stock upon vesting and settlement. 4,500 PRSUs shall vest upon satisfaction of three escalating share price vesting milestones, and the remaining PRSUs vest upon satisfaction of certain discovery and clinical milestones."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each performance restricted stock unit (\"PRSU\") represents the contingent right to receive one share of the Issuer's Common Stock upon vesting and settlement. 4,500 PRSUs shall vest upon satisfaction of three escalating share price vesting milestones, and the remaining PRSUs vest upon satisfaction of certain discovery and clinical milestones."}],"balance_after":22500,"derivative":{"expiration_date":"2025-02-28","underlying":"Common Stock","underlying_shares":3750},"source":{"system":"sec-edgar","filing":"0001209191-22-032511","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1662579/000120919122032511/doc4.xml","form_type":"4"}},{"id":2252690,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":87471,"kind":"person","name":"Fisher Stewart","position":1,"cik":"0001824863","reported_name":"Fisher Stewart","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2022-05-27T20:15:50.000Z","date":"2022-05-25","kind":"exercise","acquired":true,"shares":3750,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each performance restricted stock unit (\"PRSU\") represents the contingent right to receive one share of the Issuer's Common Stock upon vesting and settlement. 4,500 PRSUs shall vest upon satisfaction of three escalating share price vesting milestones, and the remaining PRSUs vest upon satisfaction of certain discovery and clinical milestones."}],"balance_after":75140,"source":{"system":"sec-edgar","filing":"0001209191-22-032511","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1662579/000120919122032511/doc4.xml","form_type":"4"}},{"id":2298175,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":87471,"kind":"person","name":"Fisher Stewart","position":1,"cik":"0001824863","reported_name":"Fisher Stewart","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-04-13T00:41:18.000Z","date":"2022-04-12","kind":"exercise","acquired":false,"shares":25928,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option vests and becomes exercisable in 20 equal quarterly installments, with the first installment vested on September 5, 2020."}],"balance_after":48152,"derivative":{"exercise_price":4.98,"expiration_date":"2030-07-08","underlying":"Common Stock","underlying_shares":25928},"source":{"system":"sec-edgar","filing":"0001209191-22-024228","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1662579/000120919122024228/doc4.xml","form_type":"4"}},{"id":2298174,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":87471,"kind":"person","name":"Fisher Stewart","position":1,"cik":"0001824863","reported_name":"Fisher Stewart","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-04-13T00:41:18.000Z","date":"2022-04-12","kind":"exercise","acquired":false,"shares":2156,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"20% of this option vested and became exercisable on May 1, 2019, with the remainder vesting in 16 equal quarterly installments thereafter."}],"balance_after":35572,"derivative":{"exercise_price":3.71,"expiration_date":"2028-04-23","underlying":"Common Stock","underlying_shares":2156},"source":{"system":"sec-edgar","filing":"0001209191-22-024228","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1662579/000120919122024228/doc4.xml","form_type":"4"}},{"id":2298173,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":87471,"kind":"person","name":"Fisher Stewart","position":1,"cik":"0001824863","reported_name":"Fisher Stewart","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2022-04-13T00:41:18.000Z","date":"2022-04-12","kind":"exercise","acquired":true,"shares":25928,"price":4.98,"value":129121.44,"ownership":{"direct":true},"balance_after":71390,"source":{"system":"sec-edgar","filing":"0001209191-22-024228","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1662579/000120919122024228/doc4.xml","form_type":"4"}},{"id":2298172,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":87471,"kind":"person","name":"Fisher Stewart","position":1,"cik":"0001824863","reported_name":"Fisher Stewart","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2022-04-13T00:41:18.000Z","date":"2022-04-12","kind":"exercise","acquired":true,"shares":2156,"price":3.71,"value":7998.76,"ownership":{"direct":true},"balance_after":45462,"source":{"system":"sec-edgar","filing":"0001209191-22-024228","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1662579/000120919122024228/doc4.xml","form_type":"4"}},{"id":2391239,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":87471,"kind":"person","name":"Fisher Stewart","position":1,"cik":"0001824863","reported_name":"Fisher Stewart","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Performance Restricted Stock Units","published_at":"2022-02-16T21:30:33.000Z","date":"2022-02-14","kind":"grant","acquired":true,"shares":26250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each performance restricted stock unit (\"PRSU\") represents the contingent right to receive one share of the Issuer's Common Stock upon vesting and settlement. 4,500 PRSUs shall vest upon satisfaction of three escalating share price vesting milestones, and the remaining 21,750 PRSUs shall vest upon satisfaction of certain discovery and clinical milestones."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each performance restricted stock unit (\"PRSU\") represents the contingent right to receive one share of the Issuer's Common Stock upon vesting and settlement. 4,500 PRSUs shall vest upon satisfaction of three escalating share price vesting milestones, and the remaining 21,750 PRSUs shall vest upon satisfaction of certain discovery and clinical milestones."}],"balance_after":26250,"derivative":{"expiration_date":"2025-02-28","underlying":"Common Stock","underlying_shares":26250},"source":{"system":"sec-edgar","filing":"0001209191-22-010208","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1662579/000120919122010208/doc4.xml","form_type":"4"}},{"id":2391238,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":87471,"kind":"person","name":"Fisher Stewart","position":1,"cik":"0001824863","reported_name":"Fisher Stewart","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-02-16T21:30:33.000Z","date":"2022-02-14","kind":"grant","acquired":true,"shares":118000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option shall vest and become exercisable in sixteen equal quarterly installments following the grant date, with the first installment vesting on May 14, 2022."}],"balance_after":118000,"derivative":{"exercise_price":22.71,"expiration_date":"2032-02-13","underlying":"Common Stock","underlying_shares":118000},"source":{"system":"sec-edgar","filing":"0001209191-22-010208","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1662579/000120919122010208/doc4.xml","form_type":"4"}},{"id":2476739,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":87471,"kind":"person","name":"Fisher Stewart","position":1,"cik":"0001824863","reported_name":"Fisher Stewart","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-12-10T21:30:26.000Z","date":"2021-12-08","kind":"exercise","acquired":false,"shares":403,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option shall vest and become exercisable in 20 equal quarterly installments, with the first installment vesting on September 5, 2020."}],"balance_after":203994,"derivative":{"exercise_price":4.98,"expiration_date":"2030-07-02","underlying":"Common Stock","underlying_shares":403},"source":{"system":"sec-edgar","filing":"0001209191-21-069036","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1662579/000120919121069036/doc4.xml","form_type":"4"}},{"id":2476738,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":87471,"kind":"person","name":"Fisher Stewart","position":1,"cik":"0001824863","reported_name":"Fisher Stewart","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-12-10T21:30:26.000Z","date":"2021-12-08","kind":"exercise","acquired":false,"shares":17786,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"20% of this option vested and became exercisable on May 1, 2019, with the remainder vesting in 16 equal quarterly installments thereafter."}],"balance_after":37728,"derivative":{"exercise_price":3.71,"expiration_date":"2028-04-23","underlying":"Common Stock","underlying_shares":17786},"source":{"system":"sec-edgar","filing":"0001209191-21-069036","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1662579/000120919121069036/doc4.xml","form_type":"4"}},{"id":2476737,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":87471,"kind":"person","name":"Fisher Stewart","position":1,"cik":"0001824863","reported_name":"Fisher Stewart","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-12-10T21:30:26.000Z","date":"2021-12-08","kind":"exercise","acquired":false,"shares":2373,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option is fully vested and exercisable as of the date hereof."}],"balance_after":0,"derivative":{"exercise_price":2.11,"expiration_date":"2026-07-12","underlying":"Common Stock","underlying_shares":2373},"source":{"system":"sec-edgar","filing":"0001209191-21-069036","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1662579/000120919121069036/doc4.xml","form_type":"4"}},{"id":2476736,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":87471,"kind":"person","name":"Fisher Stewart","position":1,"cik":"0001824863","reported_name":"Fisher Stewart","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-12-10T21:30:26.000Z","date":"2021-12-08","kind":"exercise","acquired":true,"shares":403,"price":4.98,"value":2006.94,"ownership":{"direct":true},"balance_after":43306,"source":{"system":"sec-edgar","filing":"0001209191-21-069036","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1662579/000120919121069036/doc4.xml","form_type":"4"}},{"id":2476735,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":87471,"kind":"person","name":"Fisher Stewart","position":1,"cik":"0001824863","reported_name":"Fisher Stewart","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-12-10T21:30:26.000Z","date":"2021-12-08","kind":"exercise","acquired":true,"shares":17786,"price":3.71,"value":65986.06,"ownership":{"direct":true},"balance_after":42903,"source":{"system":"sec-edgar","filing":"0001209191-21-069036","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1662579/000120919121069036/doc4.xml","form_type":"4"}},{"id":2476734,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":87471,"kind":"person","name":"Fisher Stewart","position":1,"cik":"0001824863","reported_name":"Fisher Stewart","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-12-10T21:30:26.000Z","date":"2021-12-08","kind":"exercise","acquired":true,"shares":2373,"price":2.11,"value":5007.03,"ownership":{"direct":true},"balance_after":25117,"source":{"system":"sec-edgar","filing":"0001209191-21-069036","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1662579/000120919121069036/doc4.xml","form_type":"4"}},{"id":2612487,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":87471,"kind":"person","name":"Fisher Stewart","position":1,"cik":"0001824863","reported_name":"Fisher Stewart","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-08-05T23:34:09.000Z","date":"2021-08-03","kind":"sale","acquired":false,"shares":17057,"price":45.0145,"value":767812.3265,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on March 12, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $45.00 to $45.10. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request."}],"balance_after":22744,"source":{"system":"sec-edgar","filing":"0001209191-21-050055","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1662579/000120919121050055/doc4.xml","form_type":"4"}},{"id":2619657,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":87471,"kind":"person","name":"Fisher Stewart","position":1,"cik":"0001824863","reported_name":"Fisher Stewart","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-08-02T22:46:27.000Z","date":"2021-08-02","kind":"sale","acquired":false,"shares":18104,"price":45.0042,"value":814756.0368,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on March 12, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $45.00 to $45.07. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request."}],"balance_after":39801,"source":{"system":"sec-edgar","filing":"0001209191-21-049116","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1662579/000120919121049116/doc4.xml","form_type":"4"}},{"id":2619656,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":87471,"kind":"person","name":"Fisher Stewart","position":1,"cik":"0001824863","reported_name":"Fisher Stewart","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-08-02T22:46:27.000Z","date":"2021-07-29","kind":"sale","acquired":false,"shares":50211,"price":45.0027,"value":2259630.5697,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on March 12, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $45.00 to $45.085. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request."}],"balance_after":57905,"source":{"system":"sec-edgar","filing":"0001209191-21-049116","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1662579/000120919121049116/doc4.xml","form_type":"4"}},{"id":2858235,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":87471,"kind":"person","name":"Fisher Stewart","position":1,"cik":"0001824863","reported_name":"Fisher Stewart","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-02-16T21:15:44.000Z","date":"2021-02-11","kind":"grant","acquired":true,"shares":94950,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest and become exercisable in 16 equal quarterly installments, with the first installment vesting on May 11, 2021."}],"balance_after":94950,"derivative":{"exercise_price":45.54,"expiration_date":"2031-02-10","underlying":"Common Stock","underlying_shares":94950},"source":{"system":"sec-edgar","filing":"0001209191-21-010710","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1662579/000120919121010710/doc4.xml","form_type":"4"}},{"id":2878715,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":87471,"kind":"person","name":"Fisher Stewart","position":1,"cik":"0001824863","reported_name":"Fisher Stewart","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-02-04T21:35:15.000Z","date":"2021-02-03","kind":"exercise","acquired":false,"shares":5929,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Form 3 filed on October 1, 2020 included an incorrect exercise price in Table II, Column 2 ($3.72)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Represents underlying unexercised stock options that were granted on April 24, 2018. The terms of the original grant provide that 20% of this option vested and became exercisable on May 1, 2019, with the remainder vesting in 16 equal quarterly installments thereafter."}],"balance_after":55514,"derivative":{"exercise_price":3.71,"expiration_date":"2028-04-23","underlying":"Common Stock","underlying_shares":5929},"source":{"system":"sec-edgar","filing":"0001209191-21-007740","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1662579/000120919121007740/doc4.xml","form_type":"4"}},{"id":2878714,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":87471,"kind":"person","name":"Fisher Stewart","position":1,"cik":"0001824863","reported_name":"Fisher Stewart","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-02-04T21:35:15.000Z","date":"2021-02-03","kind":"exercise","acquired":false,"shares":2371,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Represents underlying unexercised stock options that were granted on July 13, 2016. The terms of the original grant provide that 20% of this option vested and became exercisable on May 2, 2017, with the remainder vesting in 16 equal quarterly installments thereafter."}],"balance_after":2371,"derivative":{"exercise_price":2.11,"expiration_date":"2026-07-12","underlying":"Common Stock","underlying_shares":2371},"source":{"system":"sec-edgar","filing":"0001209191-21-007740","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1662579/000120919121007740/doc4.xml","form_type":"4"}},{"id":2878713,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":87471,"kind":"person","name":"Fisher Stewart","position":1,"cik":"0001824863","reported_name":"Fisher Stewart","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-02-04T21:35:15.000Z","date":"2020-12-11","kind":"exercise","acquired":false,"shares":9701,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Form 3 filed on October 1, 2020 included an incorrect exercise price in Table II, Column 2 ($3.72)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Represents underlying unexercised stock options that were granted on April 24, 2018. The terms of the original grant provide that 20% of this option vested and became exercisable on May 1, 2019, with the remainder vesting in 16 equal quarterly installments thereafter."}],"balance_after":61443,"derivative":{"exercise_price":3.71,"expiration_date":"2028-04-23","underlying":"Common Stock","underlying_shares":9701},"source":{"system":"sec-edgar","filing":"0001209191-21-007740","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1662579/000120919121007740/doc4.xml","form_type":"4"}},{"id":2878712,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":87471,"kind":"person","name":"Fisher Stewart","position":1,"cik":"0001824863","reported_name":"Fisher Stewart","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-02-04T21:35:15.000Z","date":"2020-12-11","kind":"exercise","acquired":false,"shares":4743,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Represents underlying unexercised stock options that were granted on July 13, 2016. The terms of the original grant provide that 20% of this option vested and became exercisable on May 2, 2017, with the remainder vesting in 16 equal quarterly installments thereafter."}],"balance_after":4742,"derivative":{"exercise_price":2.11,"expiration_date":"2026-07-12","underlying":"Common Stock","underlying_shares":4743},"source":{"system":"sec-edgar","filing":"0001209191-21-007740","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1662579/000120919121007740/doc4.xml","form_type":"4"}},{"id":2878711,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":87471,"kind":"person","name":"Fisher Stewart","position":1,"cik":"0001824863","reported_name":"Fisher Stewart","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-02-04T21:35:15.000Z","date":"2021-02-03","kind":"exercise","acquired":true,"shares":5929,"price":3.71,"value":21996.59,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Form 3 filed on October 1, 2020 included an incorrect exercise price in Table II, Column 2 ($3.72)."}],"balance_after":108116,"source":{"system":"sec-edgar","filing":"0001209191-21-007740","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1662579/000120919121007740/doc4.xml","form_type":"4"}},{"id":2878710,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":87471,"kind":"person","name":"Fisher Stewart","position":1,"cik":"0001824863","reported_name":"Fisher Stewart","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-02-04T21:35:15.000Z","date":"2021-02-03","kind":"exercise","acquired":true,"shares":2371,"price":2.11,"value":5002.81,"ownership":{"direct":true},"balance_after":102187,"source":{"system":"sec-edgar","filing":"0001209191-21-007740","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1662579/000120919121007740/doc4.xml","form_type":"4"}},{"id":2878709,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":87471,"kind":"person","name":"Fisher Stewart","position":1,"cik":"0001824863","reported_name":"Fisher Stewart","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-02-04T21:35:15.000Z","date":"2020-12-11","kind":"exercise","acquired":true,"shares":9701,"price":3.71,"value":35990.71,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Form 3 filed on October 1, 2020 included an incorrect exercise price in Table II, Column 2 ($3.72)."}],"balance_after":99816,"source":{"system":"sec-edgar","filing":"0001209191-21-007740","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1662579/000120919121007740/doc4.xml","form_type":"4"}},{"id":2878708,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":87471,"kind":"person","name":"Fisher Stewart","position":1,"cik":"0001824863","reported_name":"Fisher Stewart","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-02-04T21:35:15.000Z","date":"2020-12-11","kind":"exercise","acquired":true,"shares":4743,"price":2.11,"value":10007.73,"ownership":{"direct":true},"balance_after":90115,"source":{"system":"sec-edgar","filing":"0001209191-21-007740","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1662579/000120919121007740/doc4.xml","form_type":"4"}}]}